Jinling Pharmaceutical (000919.SZ) subsidiary Iron Amber Chemical Raw Material Drug approved for listing.

date
22/05/2025
Smart Finance APP News, Jinling Pharmaceutical (000919.SZ) announced that its subsidiary, Chizhou Dongsheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Chizhou Dongsheng"), recently received a notice of approval for the listing application of chemical raw materials from the National Medical Products Administration (2025YS00391). The chemical raw material is called Ferrous Succinate.